ArticleCureus2026
Lymphomatosis Cerebri Presenting as Steroid-Refractory Demyelinating Disease: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphomatosis cerebri (LC) is a rare infiltrative variant of primary central nervous system lymphoma characterized by diffuse cerebral involvement without formation of a discrete mass lesion, which can mimic inflammatory demyelinating disease on imaging. We report a diagnostically challenging case of a 31-year-old man who presented with progressive bilateral visual impairment and diffuse white matter abnormalities initially managed as a demyelinating disease. Magnetic resonance imaging demonstrated widespread bilateral T2-weighted and fluid-attenuated inversion recovery hyperintensities involving the optic pathways, deep and periventricular white matter, basal ganglia, thalami, brainstem, and cerebellar peduncle, with minimal contrast enhancement and mild diffusion restriction. The patient failed to improve despite treatment with high-dose corticosteroids and other immunomodulatory therapies and subsequently developed seizures with progressive neurological deterioration. Extensive laboratory and cerebrospinal fluid evaluation did not support an inflammatory, infectious, or autoimmune etiology. Stereotactic brain biopsy performed due to clinical progression revealed diffuse angiocentric infiltration by malignant lymphoid cells, confirming the diagnosis of LC. This case highlights the potential for LC to masquerade as steroid-refractory demyelinating disease and underscores the importance of recognizing suggestive imaging patterns that should prompt early consideration of brain biopsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.